<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T02:02:39Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:9877107" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:9877107</identifier>
        <datestamp>2023-04-13</datestamp>
        <setSpec>blackwellopen</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" id="oby23564" xml:lang="en" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Obesity (Silver Spring)</journal-id>
              <journal-id journal-id-type="iso-abbrev">Obesity (Silver Spring)</journal-id>
              <journal-id journal-id-type="doi">10.1002/(ISSN)1930-739X</journal-id>
              <journal-id journal-id-type="publisher-id">OBY</journal-id>
              <journal-title-group>
                <journal-title>Obesity (Silver Spring, Md.)</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">1930-7381</issn>
              <issn pub-type="epub">1930-739X</issn>
              <publisher>
                <publisher-name>John Wiley and Sons Inc.</publisher-name>
                <publisher-loc>Hoboken</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC9877107</article-id>
              <article-id pub-id-type="pmcid">PMC9877107</article-id>
              <article-id pub-id-type="pmc-uid">9877107</article-id>
              <article-id pub-id-type="pmid">36229981</article-id>
              <article-id pub-id-type="pmid">36229981</article-id>
              <article-id pub-id-type="doi">10.1002/oby.23564</article-id>
              <article-id pub-id-type="publisher-id">OBY23564</article-id>
              <article-categories>
                <subj-group subj-group-type="overline">
                  <subject>Original Article</subject>
                </subj-group>
                <subj-group subj-group-type="heading">
                  <subject>ORIGINAL ARTICLES</subject>
                  <subj-group subj-group-type="heading">
                    <subject>Time‐Restricted Eating</subject>
                  </subj-group>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Early <styled-content style="fixed-case" toggle="no">time‐restricted</styled-content> feeding improves <styled-content style="fixed-case" toggle="no">high‐density</styled-content> lipoprotein amount and function in nonhuman primates, without effects on body composition</article-title>
                <alt-title alt-title-type="right-running-head">EARLY TIME‐RESTRICTED FEEDING IMPROVES <styled-content style="fixed-case" toggle="no">HDL</styled-content> FUNCTION</alt-title>
              </title-group>
              <contrib-group>
                <contrib id="oby23564-cr-0001" contrib-type="author" corresp="yes">
                  <name>
                    <surname>Kavanagh</surname>
                    <given-names>Kylie</given-names>
                  </name>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-8772-6186</contrib-id>
                  <xref rid="oby23564-aff-0001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <xref rid="oby23564-aff-0002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                  <xref rid="oby23564-aff-0003" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                  <address>
                    <email>kkavanag@wakehealth.edu</email>
                  </address>
                </contrib>
                <contrib id="oby23564-cr-0002" contrib-type="author">
                  <name>
                    <surname>Bashore</surname>
                    <given-names>Alexander C.</given-names>
                  </name>
                  <xref rid="oby23564-aff-0003" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib id="oby23564-cr-0003" contrib-type="author">
                  <name>
                    <surname>Davis</surname>
                    <given-names>Matthew A.</given-names>
                  </name>
                  <xref rid="oby23564-aff-0003" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib id="oby23564-cr-0004" contrib-type="author">
                  <name>
                    <surname>Jorgensen</surname>
                    <given-names>Matthew J.</given-names>
                  </name>
                  <xref rid="oby23564-aff-0001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib id="oby23564-cr-0005" contrib-type="author">
                  <name>
                    <surname>McClouth</surname>
                    <given-names>Christopher J.</given-names>
                  </name>
                  <xref rid="oby23564-aff-0004" ref-type="aff">
                    <sup>4</sup>
                  </xref>
                </contrib>
                <contrib id="oby23564-cr-0006" contrib-type="author">
                  <name>
                    <surname>Beavers</surname>
                    <given-names>Daniel A.</given-names>
                  </name>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-4286-9463</contrib-id>
                  <xref rid="oby23564-aff-0004" ref-type="aff">
                    <sup>4</sup>
                  </xref>
                </contrib>
                <contrib id="oby23564-cr-0007" contrib-type="author">
                  <name>
                    <surname>Parks</surname>
                    <given-names>John S.</given-names>
                  </name>
                  <xref rid="oby23564-aff-0003" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                </contrib>
              </contrib-group>
              <aff id="oby23564-aff-0001">
                <label>
                  <sup>1</sup>
                </label>
                <named-content content-type="organisation-division">Department of Pathology</named-content>
                <institution>Wake Forest University School of Medicine</institution>
                <city>Winston‐Salem</city>
                <named-content content-type="country-part">North Carolina</named-content>
                <country country="US">USA</country>
              </aff>
              <aff id="oby23564-aff-0002">
                <label>
                  <sup>2</sup>
                </label>
                <named-content content-type="organisation-division">College of Health and Medicine</named-content>
                <institution>University of Tasmania</institution>
                <city>Hobart</city>
                <country country="AU">Australia</country>
              </aff>
              <aff id="oby23564-aff-0003">
                <label>
                  <sup>3</sup>
                </label>
                <named-content content-type="organisation-division">Department of Internal Medicine‐Section on Molecular Medicine</named-content>
                <institution>Wake Forest University School of Medicine</institution>
                <city>Winston‐Salem</city>
                <named-content content-type="country-part">North Carolina</named-content>
                <country country="US">USA</country>
              </aff>
              <aff id="oby23564-aff-0004">
                <label>
                  <sup>4</sup>
                </label>
                <named-content content-type="organisation-division">Department of Public Health Sciences</named-content>
                <institution>Wake Forest University School of Medicine</institution>
                <city>Winston‐Salem</city>
                <named-content content-type="country-part">North Carolina</named-content>
                <country country="US">USA</country>
              </aff>
              <author-notes>
                <corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>
Kylie Kavanagh, Wake Forest University School of Medicine, Medical Center Boulevard, Winston‐Salem, NC 27157, USA.<break/>
Email: <email>kkavanag@wakehealth.edu</email>
<break/>
</corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>13</day>
                <month>10</month>
                <year>2022</year>
              </pub-date>
              <pub-date pub-type="ppub">
                <month>2</month>
                <year>2023</year>
              </pub-date>
              <volume>31</volume>
              <issue>Suppl 1</issue>
              <issue-id pub-id-type="doi">10.1002/oby.v31.S1</issue-id>
              <fpage>75</fpage>
              <lpage>84</lpage>
              <history>
                <date date-type="rev-recd">
                  <day>04</day>
                  <month>7</month>
                  <year>2022</year>
                </date>
                <date date-type="received">
                  <day>17</day>
                  <month>5</month>
                  <year>2022</year>
                </date>
                <date date-type="accepted">
                  <day>01</day>
                  <month>8</month>
                  <year>2022</year>
                </date>
              </history>
              <permissions>
                <!--&#x000a9; 2023 The Obesity Society-->
                <copyright-statement content-type="article-copyright">© 2022 The Authors. <italic toggle="yes">Obesity</italic> published by Wiley Periodicals LLC on behalf of The Obesity Society.</copyright-statement>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref>
                  <license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link> License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf" xlink:href="file:OBY-31-75.pdf"/>
              <abstract>
                <title>Abstract</title>
                <sec id="oby23564-sec-0001">
                  <title>Objective</title>
                  <p>Time‐restricted feeding (TRF), whereby caloric intake is limited to a &lt;12‐hour window, is a potential regimen to ameliorate metabolic syndrome and cardiovascular disease (CVD) risk co‐occurring with aging and with obesity. Early TRF (eTRF; early morning feeding followed by overnight fasting) times calorie consumption with hepatic circadian gene expression rhythms. Brief TRF trials demonstrate that high‐density lipoprotein (HDL) cholesterol increases similar to diet/exercise interventions, which may impart beneficial CVD effects. Using a nonhuman primate (NHP) model, the efficacy of eTRF to raise HDL and increase plasma cholesterol efflux capacity (CEC) (primarily mediated by cholesterol efflux to HDL particles, a process that is inversely associated with CVD risk) was examined.</p>
                </sec>
                <sec id="oby23564-sec-0002">
                  <title>Methods</title>
                  <p>Adult (8–16 years old, <italic toggle="no">n</italic> = 25) and geriatric (≥17 years old) NHPs were randomized to ad libitum feeding or eTRF for 12 months, and relevant body composition, glycemic control, and plasma HDL cholesterol levels and CEC were measured.</p>
                </sec>
                <sec id="oby23564-sec-0003">
                  <title>Results</title>
                  <p>Impaired CEC was found in geriatric NHPs. eTRF induced larger‐sized HDL particles, increased HDL apolipoprotein A‐1 content, lowered triglyceride concentrations, and increased plasma CEC (primarily to HDL particles) in both adult and geriatric NHPs without changes in glycemic control or body composition.</p>
                </sec>
                <sec id="oby23564-sec-0004">
                  <title>Conclusions</title>
                  <p>A beneficial effect of eTRF on increasing HDL CEC in NHPs was demonstrated.</p>
                </sec>
              </abstract>
              <funding-group>
                <award-group id="funding-0001">
                  <funding-source>
                    <institution-wrap>
                      <institution>National Center for Advancing Translational Sciences
</institution>
                      <institution-id institution-id-type="doi">10.13039/100006108</institution-id>
                    </institution-wrap>
                  </funding-source>
                  <award-id>UL1TR001420</award-id>
                </award-group>
                <award-group id="funding-0002">
                  <funding-source>
                    <institution-wrap>
                      <institution>National Heart, Lung, and Blood Institute
</institution>
                      <institution-id institution-id-type="doi">10.13039/100000050</institution-id>
                    </institution-wrap>
                  </funding-source>
                  <award-id>R01HL119962</award-id>
                </award-group>
                <award-group id="funding-0003">
                  <funding-source>
                    <institution-wrap>
                      <institution>NIH Office of the Director
</institution>
                      <institution-id institution-id-type="doi">10.13039/100000052</institution-id>
                    </institution-wrap>
                  </funding-source>
                  <award-id>P40OD010965</award-id>
                </award-group>
              </funding-group>
              <counts>
                <fig-count count="4"/>
                <table-count count="3"/>
                <page-count count="10"/>
                <word-count count="6874"/>
              </counts>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>source-schema-version-number</meta-name>
                  <meta-value>2.0</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>cover-date</meta-name>
                  <meta-value>February 2023</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>details-of-publishers-convertor</meta-name>
                  <meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.2.7 mode:remove_FC converted:12.04.2023</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
            <notes>
              <p content-type="self-citation">
                <mixed-citation publication-type="journal" id="oby23564-cit-9001"><string-name><surname>Kavanagh</surname><given-names>K</given-names></string-name>, <string-name><surname>Bashore</surname><given-names>AC</given-names></string-name>, <string-name><surname>Davis</surname><given-names>MA</given-names></string-name>, et al. <article-title>Early <styled-content style="fixed-case" toggle="no">time‐restricted</styled-content> feeding improves <styled-content style="fixed-case" toggle="no">high‐density</styled-content> lipoprotein amount and function in nonhuman primates, without effects on body composition</article-title>. <source>Obesity (Silver Spring)</source>. <year>2023</year>;<volume>31</volume>(<issue>Suppl. 1</issue>):<fpage>75</fpage>‐<lpage>84</lpage>. doi:<pub-id pub-id-type="doi">10.1002/oby.23564</pub-id>
<pub-id pub-id-type="pmid">36229981</pub-id></mixed-citation>
              </p>
              <fn-group>
                <fn id="oby23564-note-1002">
                  <p><bold>Funding information</bold> National Center for Advancing Translational Sciences, Grant/Award Number: UL1TR001420; National Heart, Lung, and Blood Institute, Grant/Award Number: R01HL119962; NIH Office of the Director, Grant/Award Number: P40OD010965</p>
                </fn>
              </fn-group>
            </notes>
          </front>
          <body id="oby23564-body-0001">
            <p>
              <boxed-text position="anchor" content-type="box" id="oby23564-blkfxd-0001">
                <caption>
                  <title>Study Importance</title>
                </caption>
                <sec id="oby23564-sec-0007">
                  <title>What is already known?</title>
                  <p>
                    <list list-type="bullet" id="oby23564-list-0001">
                      <list-item id="oby23564-li-0001">
                        <p>Time‐restricted feeding (TRF) has been effective in improving both body composition and cardiovascular risk factors in animal models and people.</p>
                      </list-item>
                      <list-item id="oby23564-li-0002">
                        <p>Early time‐restricted feeding (eTRF) is a refinement of the strategy to match the circadian rhythmic gene expression patterns observed in tissues such as the liver.</p>
                      </list-item>
                    </list>
                  </p>
                </sec>
                <sec id="oby23564-sec-0008">
                  <title>What does this study add?</title>
                  <p>
                    <list list-type="bullet" id="oby23564-list-0002">
                      <list-item id="oby23564-li-0003">
                        <p>Geriatric nonhuman primate (NHP) plasma has deficient cholesterol efflux capacity, and long‐term exposure to eTRF in NHPs improves cholesterol efflux capacity in both adult and geriatric NHP populations.</p>
                      </list-item>
                      <list-item id="oby23564-li-0004">
                        <p>High‐density lipoprotein particles become larger and more apolipoprotein A‐1 rich with eTRF.</p>
                      </list-item>
                      <list-item id="oby23564-li-0005">
                        <p>Triglyceride levels improve with eTRF, and lipid and lipoprotein changes are seen without changes in body composition.</p>
                      </list-item>
                    </list>
                  </p>
                </sec>
                <sec id="oby23564-sec-0009">
                  <title>How might these results change the direction of research or the focus of clinical practice?</title>
                  <p>
                    <list list-type="bullet" id="oby23564-list-0003">
                      <list-item id="oby23564-li-0006">
                        <p>eTRF may be a strategy for the improvement of cardiovascular risk in adult and elderly populations.</p>
                      </list-item>
                    </list>
                  </p>
                </sec>
              </boxed-text>
            </p>
            <sec id="oby23564-sec-0010">
              <title>INTRODUCTION</title>
              <p>The developed world is rapidly aging and obesity prevalence is increasing, with the leading all‐cause mortality being attributed to cardiovascular disease (CVD) [<xref rid="oby23564-bib-0001" ref-type="bibr">1</xref>]. These risk factors, age and obesity, often lead to metabolic syndrome and high rates of polypharmacy [<xref rid="oby23564-bib-0002" ref-type="bibr">2</xref>]. Nonpharmaceutical approaches, such as diet and exercise, are universally effective, readily recommended by physicians, and generally well accepted by patients. However, these interventions are often difficult to adhere to, because people may be limited by access to affordable healthy food, may lack time and knowledge about food preparation, and may have individual preferences. Exercise also can be limited by factors that include reduced mobility, which often co‐occurs with advanced age and obesity, as well as access to spaces and adequate time to recreate [<xref rid="oby23564-bib-0003" ref-type="bibr">3</xref>]. For these reasons, time‐restricted feeding (TRF) has gained attention as a strategy that does not rely on diet change or exercise but that has beneficial effects on weight and CVD risk factors [<xref rid="oby23564-bib-0004" ref-type="bibr">4</xref>]. TRF is the concept whereby the type and amount of calories consumed are not the focus of change, but calorie consumption is limited to a less than 12‐hour window, establishing a regular periodic fasting period. TRF has shown promising effects in early clinical trials for risk factors associated with cardiometabolic diseases [<xref rid="oby23564-bib-0005" ref-type="bibr">5</xref>, <xref rid="oby23564-bib-0006" ref-type="bibr">6</xref>, <xref rid="oby23564-bib-0007" ref-type="bibr">7</xref>, <xref rid="oby23564-bib-0008" ref-type="bibr">8</xref>]. A subtle modification of TRF has been proposed based on observations of gene expression patterns having circadian rhythms [<xref rid="oby23564-bib-0006" ref-type="bibr">6</xref>, <xref rid="oby23564-bib-0009" ref-type="bibr">9</xref>]. Genes showing daily expression patterns include those expressed in liver that peak during the early morning hours [<xref rid="oby23564-bib-0009" ref-type="bibr">9</xref>]. Early TRF (eTRF) prescribes the feeding period to begin in early morning and fasting to occur overnight to match decreased circadian gene expression.</p>
              <p>Circulatory cholesterol distribution among the lipoprotein particles is a key CVD risk biomarker. Short‐term clinical trials employing a range of TRF windows, from every other day TRF to consistent 12‐hour feeding windows, have shown that high‐density lipoprotein (HDL)‐associated cholesterol (HDL‐C) increases in younger, healthier populations in a manner similar to that seen with the implementation of recommended dietary and exercise paradigms [<xref rid="oby23564-bib-0004" ref-type="bibr">4</xref>]. Improved circulatory lipid profiles, characterized by reduced low‐density lipoprotein–associated cholesterol and increased HDL‐C, lead to a reduction in CVD risk via HDL‐C–mediated reverse cholesterol transport [<xref rid="oby23564-bib-0010" ref-type="bibr">10</xref>, <xref rid="oby23564-bib-0011" ref-type="bibr">11</xref>]. HDL‐C particles convey both cardioprotective and anti‐inflammatory effects, particularly relevant to populations with overweight and geriatric populations, who commonly have higher circulating levels of inflammatory cytokines thought to impair function in multiple body systems. In recent decades, raising HDL‐C has been a prime target for pharmaceutical development, yet strategies to increase reverse cholesterol transport by HDL‐C have been largely unsuccessful [<xref rid="oby23564-bib-0010" ref-type="bibr">10</xref>, <xref rid="oby23564-bib-0011" ref-type="bibr">11</xref>, <xref rid="oby23564-bib-0012" ref-type="bibr">12</xref>, <xref rid="oby23564-bib-0013" ref-type="bibr">13</xref>].</p>
              <p>A gap in knowledge exists regarding how the positive effects of TRF on metabolic syndrome risk separate from efficacy in inducing weight loss and caloric restriction (CR). These contributions have been difficult to disentangle, as weight loss is commonly observed in TRF/CR studies [<xref rid="oby23564-bib-0004" ref-type="bibr">4</xref>, <xref rid="oby23564-bib-0014" ref-type="bibr">14</xref>]. In the current study, we employed a nonhuman primate (NHP) model with a long history of use in lipoprotein and CVD research to evaluate eTRF effects on HDL‐C [<xref rid="oby23564-bib-0015" ref-type="bibr">15</xref>, <xref rid="oby23564-bib-0016" ref-type="bibr">16</xref>]. We investigated whether chronic eTRF positively affected plasma HDL and cholesterol efflux capacity (CEC) using a highly controlled study environment with both adult and geriatric NHPs.</p>
            </sec>
            <sec sec-type="methods" id="oby23564-sec-0011">
              <title>METHODS</title>
              <sec id="oby23564-sec-0012">
                <title>Study animals</title>
                <p>All procedures were performed in accordance with the Guide for Care and Use of Laboratory Animals. Protocols for avoidance of pain and discomfort were adhered to and conducted in compliance with the Wake Forest University School of Medicine Institutional Animal Care and Use Committee. The Wake Forest School of Medicine is accredited by the Association for Assessment and Accreditation of Laboratory Animal Care International and it operates in compliance with the Animal Welfare Act.</p>
                <p>This study included both adult (≥7–16 years old) and geriatric (≥17 years old) African green monkeys (<italic toggle="yes">Chlorocebus aethiops sabaeus</italic>), maintained as part of the Wake Forest University Vervet Research Colony. The Vervet Research Colony is a multigenerational breeding NHP colony that we have studied extensively, and its metabolic health and health diversity have been previously published [<xref rid="oby23564-bib-0016" ref-type="bibr">16</xref>, <xref rid="oby23564-bib-0017" ref-type="bibr">17</xref>].</p>
                <p>All study subjects consumed commercially prepared diets. For comparison of age‐related differences in CEC, we assessed adult and geriatric monkeys while they consumed a low‐fat, low‐cholesterol, and low‐simple‐carbohydrate laboratory chow (LabDiet 5038). To assess diet‐related effects on HDL and the effects of eTRF, the monkeys were then fed a Western diet (LabDiet 5L3K), which included moderate cholesterol content (600 ppm, 3.66 kcal/g), 19.4% protein, 33.9% fat, and 46.7% carbohydrates. Simple carbohydrates composed 19% of total calories. The details of each diet are tabulated in Supporting Information Table <xref rid="oby23564-supitem-0001" ref-type="supplementary-material">S1</xref>.</p>
                <p>Following baseline assessments, adult and geriatric animals were further stratified to one of two experimental groups, receiving either ad libitum feeding (24‐hour diet access) or eTRF, wherein subjects had access to the diet only from approximately 6 AM until 2 PM daily. This 8‐hour feeding regimen is based on positive outcomes reported in small, short‐term human clinical trials [<xref rid="oby23564-bib-0006" ref-type="bibr">6</xref>, <xref rid="oby23564-bib-0007" ref-type="bibr">7</xref>, <xref rid="oby23564-bib-0018" ref-type="bibr">18</xref>, <xref rid="oby23564-bib-0019" ref-type="bibr">19</xref>] and the hypothesis that these feeding hours better align with increased circadian gene expression patterns known to exist in humans and NHPs [<xref rid="oby23564-bib-0006" ref-type="bibr">6</xref>, <xref rid="oby23564-bib-0009" ref-type="bibr">9</xref>, <xref rid="oby23564-bib-0020" ref-type="bibr">20</xref>]. Diet consumption continued for a total of 12 months, with measurements performed at regular time points as illustrated in Figure <xref rid="oby23564-fig-0001" ref-type="fig">1</xref>. The numbers in each treatment group varied, as is the case in most clinically oriented studies, based on animal availability at each time point, with group sizes indicated in table and figure legends.</p>
                <fig position="float" fig-type="FIGURE" id="oby23564-fig-0001">
                  <label>FIGURE 1</label>
                  <caption>
                    <p>Overall study schema in which adult nonhuman primates (NHPs; <italic toggle="yes">n</italic> = 25) and geriatric NHPs (<italic toggle="yes">n</italic> = 21) were fed a high‐fat, ‐sugar, and ‐cholesterol diet modeled on current Westernized countries' consumption patterns. NHPs were divided evenly into ad libitum access to food or access only between 6 a.m. and 2 p.m. in an early time‐restricted feeding (eTRF) paradigm. Cardiometabolic outcomes, including plasma cholesterol efflux capacity, were measured at selected time points during the yearlong study. A1c, glycosylation of hemoglobin chain (a biomarker of glycemic control). HDL, high‐density lipoprotein</p>
                  </caption>
                  <graphic xlink:href="OBY-31-75-g004" position="anchor" id="jats-graphic-1"/>
                </fig>
                <p>For all of the following experimental procedures, animals were fasted overnight prior to being sedated via intramuscular injection of ketamine (10 mg/kg) and midazolam (0.1 mg/kg). Blood sampling for all measurements was conducted via percutaneous femoral venipuncture.</p>
              </sec>
              <sec id="oby23564-sec-0013">
                <title>Quantification of plasma <styled-content style="fixed-case" toggle="no">CEC</styled-content> and radiolabeled cholesterol distribution among plasma lipoproteins</title>
                <p>CEC was measured in adult and geriatric animals on a low‐fat, low‐cholesterol diet to assess differences related to chronological age and also after 8 months of eTRF or ad libitum consumption of the Western diet. CEC efflux was quantified as described previously [<xref rid="oby23564-bib-0021" ref-type="bibr">21</xref>], with minor modifications. J774 macrophages were plated in 24 multiwell plates (150,000 cells/well for 24 hours) and radiolabeled with 1‐μCi/mL <sup>3</sup>H‐cholesterol (Perkin Elmer; NET139001MC) for an additional 24 hours. Phospholipid‐transporting ATPase ABCA1 was upregulated by a 20‐hour incubation with 0.3mM 8‐bromoadenosine 3′,5′‐cyclic monophosphate (8‐Br‐cAMP; Sigma; B5386). Subsequently, efflux medium containing 2% plasma was added for 4 hours. Each sample was run in triplicate, and a pooled plasma standard was used to correct for interassay variation. To correct for background efflux, plasma‐free wells were also included. Following the efflux period, medium was collected and cellular lipids were harvested by incubating cells overnight with hexane:isoproponal (3:2). Percentage efflux was calculated using the following formula: [(μCi of <sup>3</sup>H‐cholesterol in medium containing 2% plasma) ÷ (μCi of <sup>3</sup>H‐cholesterol in cell extract + μCi of <sup>3</sup>H‐cholesterol in medium)]. To calculate specific efflux, background efflux to plasma‐free wells was subtracted. To correct for interassay variation across plates, samples were normalized to the pooled plasma control.</p>
                <p>To analyze distribution of <sup>3</sup>H‐radiolabel across lipoprotein species at completion of efflux procedure, 200 μL of pooled media (equal volume from each animal) from each group was applied to a Superose 6 Increase 10/300 GL gel filtration column (GE Healthcare; 29‐0915‐96). The samples were eluted at a flow rate of 0.4 mL/min in a Tris buffer (10mM Tris, 0.15M NaCl, 1mM EDTA, 0.2% NaN<sub>3</sub>), and eluate was collected in 1‐minute fractions and radiolabel in each fraction quantified with liquid scintillation spectroscopy.</p>
              </sec>
              <sec id="oby23564-sec-0014">
                <title>Plasma measurements</title>
                <p>Lipid parameters assayed included total plasma cholesterol (TPC), HDL‐C, and triglycerides (TG). TPC was measured by enzymatic techniques based on the methods of Allain et al. [<xref rid="oby23564-bib-0022" ref-type="bibr">22</xref>]. HDL‐C concentrations were measured using a slight modification (2M MnCl<sub>2</sub>) of the heparin‐manganese precipitation procedure described in the Manual of Laboratory Operations of the Lipid Research Clinics Program. All lipid analyses were performed on an ACE Alera Clinical Chemistry System (Alfa Wasserman, Inc.) at Wake Forest University Health Sciences, which subscribes to the Centers for Disease Control and Prevention–National Heart, Lung, and Blood Institute Lipids Standardization Program.</p>
                <p>For subsequent lipoprotein measurements, an aliquot of plasma containing ~20 μg of TPC was diluted in phosphate‐buffered saline (PBS) into a volume of 400 μL. After centrifugation to remove any protein precipitates, samples were injected onto a Superose 6 HR 10/30 (Amersham Pharmacia) chromatography column run at 0.4 mL/min. Lipoprotein cholesterol was determined by multiplying the TPC concentration by the cholesterol percentage within the elution region for each lipoprotein class. The elution was mixed with cholesterol reagent that created a colorimetric signal, which was integrated using Chrom Perfect Spirit Software (Justice Laboratory Software). HDL size estimations were measured by peak retention time on the elution chromatograph for each individual. Measures were performed at baseline, 2 months, and 12 months in the eTRF interventional study. The 5‐minute eluted fractions between 30 and 45 minutes containing HDL were collected in four randomly selected animals per group for subsequent analysis of apolipoproteins. Levels of lipoprotein‐associated apolipoprotein A‐1 (ApoA‐1), ApoA‐4, and ApoE proteins and the enzymes cholesterol ester transfer protein and lecithin–cholesterol acyltransferase were measured by electrophoretic separation and immunodetection after transfer to nitrocellulose membranes, as previously described [<xref rid="oby23564-bib-0023" ref-type="bibr">23</xref>]. These measures were performed at the end of the eTRF study. The antibodies used are provided in Supporting Information Table <xref rid="oby23564-supitem-0001" ref-type="supplementary-material">S2</xref>.</p>
                <p>Glycemic control was measured by fasting plasma glucose concentrations using the glucose oxidase method, and glycosylated hemoglobin A1c (HbA1c) percentage values were measured in whole blood using a point‐of‐care diagnostic assay (Afinion Alere; Abbott). Glycemic control was measured at baseline and at study end to assess effects of eTRF.</p>
              </sec>
              <sec id="oby23564-sec-0015">
                <title>Body composition</title>
                <p>Dual‐energy X‐ray absorptiometry (Hologic Discovery A Dual X‐ray Bone Densitometer) scans were performed to quantitate overall body fat content at baseline and after 8 months of diet consumption. Body weight measures were also recorded and similarly tracked at all data time points.</p>
              </sec>
              <sec id="oby23564-sec-0016">
                <title>Statistical analyses</title>
                <p>All data were tested for normality prior to statistical assessments and transformed when necessary to allow parametric testing. A two‐factor ANOVA model (diet and age group) was applied to find differences in HDL‐related parameters prior to study and at baseline, 2 months, and study end. Body weight, body fat, HbA1c, and TG values were measured repeatedly at different time points over 12 months of study and were evaluated by linear regression models that control for initial value and group assignment. Test subject baseline value for each assessed variable was generally significant in predicting outcome. In all analyses, <italic toggle="yes">p</italic> ≤ 0.05 was considered significant. Results are reported as the statistical probability associated with each effect present in the model: diet group, age group, time, or diet × age interaction where applicable. Data are presented as means, with standard error of the mean, and the number of individuals available to sample at each assessment is indicated. The study involved applying eTRF or ad libitum feeding to an active breeding and resource colony, such that individuals may have missing data due to pregnancy, death, sale, or other experimental protocols.</p>
              </sec>
            </sec>
            <sec sec-type="results" id="oby23564-sec-0017">
              <title>RESULTS</title>
              <sec id="oby23564-sec-0018">
                <title>Age decreases <styled-content style="fixed-case" toggle="no">HDL</styled-content> function</title>
                <p>Prior to initiation of the eTRF study, we evaluated cholesterol efflux in the selected cohort of NHPs eating a typical laboratory low‐fat, ‐sugar, and ‐cholesterol chow diet. All animals had comparable housing environments and supplemental fruit and vegetables. In this cohort of NHPs, plasma CEC of geriatric monkeys (<italic toggle="yes">n</italic> = 21, mean age 21.1 ± 0.65 years; <italic toggle="yes">p</italic> &lt; 0.001) was 9% lower than adult NHPs (<italic toggle="yes">n</italic> = 25, mean age 11.7 ± 0.46 years; <italic toggle="yes">p</italic> = 0.03, Figure <xref rid="oby23564-fig-0002" ref-type="fig">2</xref>).</p>
                <fig position="float" fig-type="FIGURE" id="oby23564-fig-0002">
                  <label>FIGURE 2</label>
                  <caption>
                    <p>Geriatric nonhuman primates (NHPs; <italic toggle="yes">n</italic> = 21) have impaired plasma cholesterol efflux as compared with adult NHPs (<italic toggle="yes">n</italic> = 25). A 9% reduction was observed (*<italic toggle="yes">p</italic> = 0.03). Normalized mean efflux values (±SEM) are shown. Normalized results corrected for a pooled plasma control sample. Uncorrected mean values were 14.5% vs. 13.4% efflux in adult and geriatric samples, respectively (<italic toggle="yes">p</italic> &lt; 0.05). AU, arbitrary units</p>
                  </caption>
                  <graphic xlink:href="OBY-31-75-g001" position="anchor" id="jats-graphic-3"/>
                </fig>
              </sec>
              <sec id="oby23564-sec-0019">
                <title><styled-content style="fixed-case" toggle="no">eTRF</styled-content> improves <styled-content style="fixed-case" toggle="no">HDL</styled-content> function in geriatric and adult monkeys</title>
                <p>Plasma from NHPs with eTRF of a Western diet for 8 months had increased CEC (<italic toggle="yes">p</italic> = 0.01) compared with ad libitum–fed animals, regardless of age, as illustrated in Figure <xref rid="oby23564-fig-0003" ref-type="fig">3A</xref>. Our sample sizes were smaller than comparisons shown in Figure <xref rid="oby23564-fig-0001" ref-type="fig">1</xref>, so a statistically significant interaction between age group and intervention effect was not detected (<italic toggle="yes">p</italic> = 0.74). These data suggest that eTRF is equally, if not more, effective in the geriatric NHP population. To determine which lipoprotein fractions were responsible for the improved CEC in plasma from eTRF animals, efflux media was size fractionated by fast protein liquid chromatography (FPLC), and radiolabeled cholesterol distributions among plasma lipoprotein fractions were quantified (Figure <xref rid="oby23564-fig-0003" ref-type="fig">3B</xref>). More radiolabeled cholesterol was found in HDL fractions (elution time near 40 minutes) from adult and geriatric monkeys in the eTRF group compared with their respective ad libitum–fed counterparts.</p>
                <fig position="float" fig-type="FIGURE" id="oby23564-fig-0003">
                  <label>FIGURE 3</label>
                  <caption>
                    <p>(A) Early time‐restricted feeding (eTRF) restores plasma efflux capacity in both adult and geriatric nonhuman primates (NHPs). The positive effect of eTRF was significant (**<italic toggle="yes">p</italic> = 0.01) and equivalent in geriatric NHPs as compared with younger adults (diet × age <italic toggle="yes">p</italic> = 0.74). Sample sizes appear as integers shown on the data columns. Normalized mean efflux values (±SEM) are shown. Unadjusted values showed adults improving from 13.2% to 14.8% and geriatrics from 12.4% to 14.5% with eTRF (<italic toggle="yes">p</italic> &lt; 0.05). (B) Media from efflux experiments were chromatographically separated to show higher counts in eTRF groups in the ≈40‐minute range, which corresponds to the high‐density lipoprotein (HDL) fractions. Lower counts are present in the earlier peaks corresponding to very low‐density lipoprotein (VLDL) and low‐density lipoprotein (LDL) particles. Pooled media for each group were evaluated, with each animal equally represented in the sample. AU, arbitrary units.</p>
                  </caption>
                  <graphic xlink:href="OBY-31-75-g002" position="anchor" id="jats-graphic-5"/>
                </fig>
              </sec>
              <sec id="oby23564-sec-0020">
                <title><styled-content style="fixed-case" toggle="no">eTRF</styled-content> is associated with more and larger <styled-content style="fixed-case" toggle="no">HDL</styled-content> particles enriched with <styled-content style="fixed-case" toggle="no">ApoA‐1</styled-content>
</title>
                <p>Size chromatographic results clearly demonstrate that eTRF treatment led to larger and more cholesterol‐rich HDL‐C particles, as indicated by significantly (<italic toggle="yes">p</italic> = 0.03) shorter column retention times regardless of subject age (Figure <xref rid="oby23564-fig-0004" ref-type="fig">4A,B</xref>). Larger HDL particles had more ApoA‐1 associated with them (<italic toggle="yes">p</italic> = 0.01 for the effect of eTRF); ApoA‐1 results (Figure <xref rid="oby23564-fig-0004" ref-type="fig">4A,B</xref>) were also substantiated by HDL‐C and TPC measures in plasma (Table <xref rid="oby23564-tbl-0001" ref-type="table">1</xref>). TPC increased in all animals over the course of study (<italic toggle="yes">p</italic> = 0.03), consistent with moving from low‐cholesterol to high‐cholesterol dietary exposure. Group differences were not significant; however, the increases in TPC in both ad libitum and eTRF groups were numerically greater in geriatric animals over the course of study (ad libitum adults increased 7% and geriatric increased 12%, whereas eTRF adults increased 8% and geriatric increased 14%). HDL‐C also increased in all groups over the study (<italic toggle="yes">p</italic> = 0.007). We believe the increase in total cholesterol mostly moved to the HDL fraction, making them larger. eTRF adult monkeys had 36% higher ApoA‐1 and eTRF geriatric monkeys had 46% higher ApoA‐1 levels in their plasma HDL fraction (<italic toggle="yes">p</italic> = 0.01 for both; Figure <xref rid="oby23564-fig-0004" ref-type="fig">4A,B</xref>). We also measured ApoA‐4 and ApoE, which may affect HDL function, and no differences were observed by age or diet grouping (Table <xref rid="oby23564-tbl-0002" ref-type="table">2</xref>).</p>
                <fig position="float" fig-type="FIGURE" id="oby23564-fig-0004">
                  <label>FIGURE 4</label>
                  <caption>
                    <p>A high‐density lipoprotein (HDL) particle size was estimated based on chromatographic retention times. Average chromatograms are shown. Adult retention times for HDL were 39.1 minutes with ad libitum feeding and 38 minutes with early time‐restricted feeding (eTRF). Geriatric HDL retention times were 38.6 minutes with ad libitum feeding and 38 minutes with eTRF (<italic toggle="yes">p</italic> = 0.03 for the overall effect of eTRF). (B) Larger HDL particles had more associated ApoA‐1 (**<italic toggle="yes">p</italic> = 0.01 for the effect of eTRF). Adult nonhuman primates (NHPs) maintained on eTRF had 36% higher ApoA‐1 and geriatric NHPs had 46% higher ApoA‐1 levels in their plasma HDL fractions. Group sizes evaluated were four per age and diet group. LDL, low‐density lipoprotein; VLDL, very low‐density lipoprotein</p>
                  </caption>
                  <graphic xlink:href="OBY-31-75-g003" position="anchor" id="jats-graphic-7"/>
                </fig>
                <table-wrap position="float" id="oby23564-tbl-0001" content-type="TABLE">
                  <label>TABLE 1</label>
                  <caption>
                    <p>Plasma lipid measures, including TPC, HDL‐C, and TG, at baseline and after 12 months on study</p>
                  </caption>
                  <table frame="hsides" rules="cols">
                    <col align="left" span="1"/>
                    <col align="char" char="±" span="1"/>
                    <col align="char" char="±" span="1"/>
                    <col align="char" char="±" span="1"/>
                    <col align="char" char="±" span="1"/>
                    <thead valign="bottom">
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" valign="bottom" rowspan="1" colspan="1"/>
                        <th colspan="2" align="left" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">Ad libitum</th>
                        <th colspan="2" align="left" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">eTRF</th>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <th style="border-bottom:solid 1px #000000" align="left" valign="bottom" rowspan="1" colspan="1"/>
                        <th align="left" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1" colspan="1">Adult</th>
                        <th align="left" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1" colspan="1">Geriatric</th>
                        <th align="left" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1" colspan="1">Adult</th>
                        <th align="left" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1" colspan="1">Geriatric</th>
                      </tr>
                    </thead>
                    <tbody valign="top">
                      <tr>
                        <td colspan="5" align="left" valign="top" rowspan="1">TPC (mg/dL)</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Baseline</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">140.1 ± 6.7</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">140.0 ± 17.1</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">155.0 ± 12.8</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">156.8 ± 14.5</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">2 months</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">148.8 ± 18.0</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">170.1 ± 14.0</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">174.5 ± 23.6</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">184.0 ± 14.9</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">12 months</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">149.8 ± 15.1</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">157.1 ± 16.5</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">167.3 ± 17.9</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">178.8 ± 11.1</td>
                      </tr>
                      <tr>
                        <td colspan="5" align="left" valign="top" rowspan="1">HDL‐C (mg/dL)</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Baseline</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">60.1 ± 2.9</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">50.8 ± 6.0</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">72.0 ± 6.2</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">66.7 ± 6.9</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">2 months</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">58.1 ± 10.2</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">64.5 ± 3.3</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">72.3 ± 14.6</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">73.7 ± 9.1</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">12 months</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">70.0 ± 8.3</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">59.7 ± 7.5</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">77.4 ± 13.2</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">78.5 ± 6.3</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">TG (mg/dL)</td>
                        <td align="char" valign="top" rowspan="1" colspan="1"/>
                        <td align="char" valign="top" rowspan="1" colspan="1"/>
                        <td colspan="2" align="char" valign="top" rowspan="1">
                          <xref rid="oby23564-note-0002" ref-type="table-fn">*</xref>
                        </td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Baseline</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">63.1 ± 5.9</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">68.6 ± 9.4</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">57.3 ± 7.7</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">78.3 ± 12.5</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">2 months</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">58.1 ± 6.9</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">69.4 ± 6.9</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">48.0 ± 5.0</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">61.3 ± 8.5</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">12 months</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">48.4 ± 6.8</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">73.0 ± 8.2</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">39.4 ± 6.4</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">67.9 ± 13.6</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot id="oby23564-ntgp-0001">
                    <fn id="oby23564-note-0001">
                      <p><italic toggle="yes">Note</italic>: Values displayed are mean ± SEM (<italic toggle="yes">n</italic> = 7–9/group). A significant effect of time was present with all groups showing an increase in TPC (<italic toggle="yes">p</italic> = 0.03) as a result of exposure to a cholesterol‐containing diet. Interactions with age and diet group were nonsignificant.</p>
                    </fn>
                    <fn id="oby23564-note-0003">
                      <p>Abbreviations: eTRF, early time‐restricted feeding; HDL‐C, high‐density lipoprotein cholesterol; TG, triglycerides; TPC, total plasma cholesterol.</p>
                    </fn>
                    <fn id="oby23564-note-0002">
                      <label>*</label>
                      <p><italic toggle="yes">p</italic> &lt; 0.05, overall effect of eTRF lowering TG vs. ad libitum feeding.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <table-wrap position="float" id="oby23564-tbl-0002" content-type="TABLE">
                  <label>TABLE 2</label>
                  <caption>
                    <p>Lipoprotein measurements, including ApoA‐4, CETP, and LCAT, in a randomly selected subset of animals (<italic toggle="no">n</italic> = 4 per group) after 8 months on study</p>
                  </caption>
                  <table frame="hsides" rules="cols">
                    <col align="left" span="1"/>
                    <col align="char" char="." span="1"/>
                    <col align="char" char="±" span="1"/>
                    <col align="char" char="±" span="1"/>
                    <col align="char" char="." span="1"/>
                    <thead valign="bottom">
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" valign="bottom" rowspan="1" colspan="1"/>
                        <th align="left" valign="bottom" rowspan="1" colspan="1">ApoA‐4</th>
                        <th align="left" valign="bottom" rowspan="1" colspan="1">ApoE</th>
                        <th align="left" valign="bottom" rowspan="1" colspan="1">CETP</th>
                        <th align="left" valign="bottom" rowspan="1" colspan="1">LCAT</th>
                      </tr>
                    </thead>
                    <tbody valign="top">
                      <tr>
                        <td colspan="5" align="left" valign="top" rowspan="1">Ad libitum</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Adult</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">1.63 ± 0.61</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">0.21 ± 0.02</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">1.49 ± 0.24</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">0.099 ± 0.01</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Geriatric</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">2.47 ± 0.32</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">0.257 ± 0.04</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">1.26 ± 0.19</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">0.133 ± 0.02</td>
                      </tr>
                      <tr>
                        <td colspan="5" align="left" valign="top" rowspan="1">eTRF</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Adult</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">2.39 ± 0.31</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">0.278 ± 0.04</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">1.33 ± 0.24</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">0.083 ± 0.0.03</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Geriatric</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">1.99 ± 0.19</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">0.272 ± 0.04</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">0.998 ± 0.07</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">0.103 ± 0.017</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">p</italic> value for ad libitum vs. eTRF</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">0.69</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">0.73</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">0.39</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">0.32</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot id="oby23564-ntgp-0002">
                    <fn id="oby23564-note-0004">
                      <p><italic toggle="yes">Note</italic>: Values displayed are mean ± SEM; units are AU/μg plasma protein × 10<sup>8</sup>.</p>
                    </fn>
                    <fn id="oby23564-note-0005">
                      <p>Abbreviations: CETP, cholesterol ester transfer protein; eTRF, early time‐restricted feeding; LCAT, lecithin–cholesterol acyltransferase.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
              </sec>
              <sec id="oby23564-sec-0021">
                <title>TG profiles improved with <styled-content style="fixed-case" toggle="no">eTRF</styled-content> in the absence of changes in adiposity or glycemic control</title>
                <p>Controlled for baseline values, eTRF significantly reduced plasma TG concentrations (Table <xref rid="oby23564-tbl-0001" ref-type="table">1</xref>; <italic toggle="yes">p</italic> = 0.014), with an overall reduction of 12.1 mg/dL with eTRF when variables of age, body weight, and time were controlled for, and no difference in adult versus geriatric groups was present. The duration of study also did not change the magnitude of the effect of eTRF (<italic toggle="yes">p</italic> = 0.91). All improvements in TG and HDL were independent of changes in adiposity or improvements in glycemic control (Table <xref rid="oby23564-tbl-0003" ref-type="table">3</xref>). This is an important distinguishing feature of this monkey study; human clinical trials are commonly confounded by improvement in body composition in the control or comparison groups [<xref rid="oby23564-bib-0019" ref-type="bibr">19</xref>]. HbA1c showed that no significant time × group interaction was noted after 12 months (Table <xref rid="oby23564-tbl-0003" ref-type="table">3</xref>; <italic toggle="yes">p</italic> = 0.10). One geriatric animal in the eTRF group became diabetic, which is reflected in the average and variability estimates of HbA1c in this group at 12 months. Body weight and composition are presented in Table <xref rid="oby23564-tbl-0003" ref-type="table">3</xref>, with comparable differences that remained consistent across time observed between the groups (group × time <italic toggle="yes">p</italic> = 0.87; Supporting Information Table <xref rid="oby23564-supitem-0001" ref-type="supplementary-material">S4</xref>). Dual‐energy X‐ray absorptiometry scans (Supporting Information Table <xref rid="oby23564-supitem-0001" ref-type="supplementary-material">S5</xref>) performed at baseline and after 8 months demonstrated that lean mass remained unchanged over time (<italic toggle="yes">p</italic> = 0.91), and both groups lost comparable, but not statistically significant, amounts of body fat (<italic toggle="yes">p</italic> = 0.65). Data for adjusted HbA1c levels by diet condition across time are presented in Supporting Information Table <xref rid="oby23564-supitem-0001" ref-type="supplementary-material">S6</xref>.</p>
                <table-wrap position="float" id="oby23564-tbl-0003" content-type="TABLE">
                  <label>TABLE 3</label>
                  <caption>
                    <p>Metabolic and glycemic indices, including body weight, percentage body fat (via DXA scan), plasma glucose, and HbA1c</p>
                  </caption>
                  <table frame="hsides" rules="cols">
                    <col align="left" span="1"/>
                    <col align="char" char="±" span="1"/>
                    <col align="char" char="±" span="1"/>
                    <col align="char" char="±" span="1"/>
                    <col align="char" char="±" span="1"/>
                    <thead valign="bottom">
                      <tr style="border-bottom:solid 1px #000000">
                        <th rowspan="2" style="border-bottom:solid 1px #000000" align="left" valign="bottom" colspan="1"/>
                        <th colspan="2" align="left" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">Ad libitum</th>
                        <th colspan="2" align="left" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">eTRF</th>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" valign="bottom" rowspan="1" colspan="1">Adult</th>
                        <th align="left" valign="bottom" rowspan="1" colspan="1">Geriatric</th>
                        <th align="left" valign="bottom" rowspan="1" colspan="1">Adult</th>
                        <th align="left" valign="bottom" rowspan="1" colspan="1">Geriatric</th>
                      </tr>
                    </thead>
                    <tbody valign="top">
                      <tr>
                        <td colspan="5" align="left" valign="top" rowspan="1">Body weight (kg)</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Baseline</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">7.18 ± 0.48</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">5.21 ± 1.76</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">6.43 ± 0.57</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">5.05 ± 0.87</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">2 months</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">7.27 ± 0.07</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">4.91 ± 1.62</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">6.22 ± 0.31</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">4.81 ± 0.88</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">8 months</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">7.20 ± 0.24</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">4.70 ± 1.52</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">6.53 ± 0.35</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">4.56 ± 0.67</td>
                      </tr>
                      <tr>
                        <td colspan="5" align="left" valign="top" rowspan="1">Body fat (%)</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Baseline</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">33.1 ± 1.0</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">29.7 ± 1.4</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">27.2 ± 1.1</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">27.9 ± 1.3</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">8 months</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">31.7 ± 1.0</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">24.0 ± 1.3</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">28.8 ± 1.3</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">23.0 ± 0.8</td>
                      </tr>
                      <tr>
                        <td colspan="5" align="left" valign="top" rowspan="1">Glucose (mg/dL)</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Baseline</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">60.5 ± 1.8</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">80.0 ± 2.9</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">66.4 ± 1.7</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">66.7 ± 1.9</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">2 months</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">54.0 ± 0.8</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">61.2 ± 0.9</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">53.1 ± 0.8</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">61.3 ± 2.1</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">8 months</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">77.5 ± 1.4</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">100.4 ± 5.0</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">69.7 ± 2.9</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">116.8 ± 8.5</td>
                      </tr>
                      <tr>
                        <td colspan="5" align="left" valign="top" rowspan="1">HbA1c (%)</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">12 months</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">4.45 ± 0.08</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">4.71 ± 0.09</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">4.24 ± 0.05</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">4.59 ± 0.11</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot id="oby23564-ntgp-0003">
                    <fn id="oby23564-note-0006">
                      <p><italic toggle="yes">Note</italic>: Sample size range was 7–12 individuals per diet condition for each age grouping.</p>
                    </fn>
                    <fn id="oby23564-note-0007">
                      <p>Abbreviations: DXA, dual‐energy X‐ray absorptiometry; eTRF, early time‐restricted feeding; HbA1c, hemoglobin A1c.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
              </sec>
            </sec>
            <sec sec-type="discussion" id="oby23564-sec-0022">
              <title>DISCUSSION</title>
              <p>To our knowledge, this study is the only preclinical eTRF intervention to date, with numerous notable findings in a highly clinically relevant NHP model. We found that eTRF markedly improved NHP plasma lipid concentrations and HDL‐C composition and function, independent of changes in body weight or fat composition. Moreover, these ameliorations were equivalently robust in both adult and geriatric cohorts. As such, eTRF could be a specific recommendation for geriatric populations with, or at risk of, CVD. Furthermore, we found no associations between plasma CEC and body composition changes, further suggesting that eTRF may be effective in populations with overweight/obesity independent of weight loss.</p>
              <p>Changes reported in HDL‐C with eTRF are generally absent or exhibit very small increases, but clinical conclusions are hampered by the small number of quality trials and the short‐term nature of those that have been published [<xref rid="oby23564-bib-0008" ref-type="bibr">8</xref>, <xref rid="oby23564-bib-0019" ref-type="bibr">19</xref>, <xref rid="oby23564-bib-0024" ref-type="bibr">24</xref>]. The small HDL‐C benefits observed in other human studies mostly fail to be statistically significant and co‐occur with meaningful changes in body weight [<xref rid="oby23564-bib-0005" ref-type="bibr">5</xref>, <xref rid="oby23564-bib-0006" ref-type="bibr">6</xref>, <xref rid="oby23564-bib-0007" ref-type="bibr">7</xref>, <xref rid="oby23564-bib-0025" ref-type="bibr">25</xref>, <xref rid="oby23564-bib-0026" ref-type="bibr">26</xref>]. Weight loss typically results in the intervention arms of most TRF human studies [<xref rid="oby23564-bib-0004" ref-type="bibr">4</xref>, <xref rid="oby23564-bib-0019" ref-type="bibr">19</xref>, <xref rid="oby23564-bib-0026" ref-type="bibr">26</xref>], which can confound the interpretation of lipid changes. In the current study, we did not see increases in circulatory HDL‐C, nor improvements in body weight or glycemic measures, which is consistent with many clinical studies. It is worth noting that a significant reduction in TG was achieved with eTRF in NHPs, and this has also been a repeatable outcome in human clinical trials [<xref rid="oby23564-bib-0019" ref-type="bibr">19</xref>, <xref rid="oby23564-bib-0027" ref-type="bibr">27</xref>]. As significant and sustained weight loss is rarely achieved and the current obesity epidemic continues unabated [<xref rid="oby23564-bib-0028" ref-type="bibr">28</xref>], finding strategies that can improve health in the absence of weight loss is important.</p>
              <p>Our data demonstrate improved HDL function regardless of HDL‐C concentrations in circulation. However, this disconnect is consistent with reports that HDL levels only explain about 33% of the variance measured in cholesterol efflux assays [<xref rid="oby23564-bib-0029" ref-type="bibr">29</xref>]. Furthermore, in a large cohort study, HDL‐C concentration did not predict adverse cardiovascular incidence over a period of over 9 years [<xref rid="oby23564-bib-0011" ref-type="bibr">11</xref>]. In this analysis, Rohatgi et al. offer proof that HDL CEC is a key functional property of the HDL lipoprotein particle, independent of HDL‐C levels, and is able to predict cardiovascular events. This finding was an important advancement of knowledge gained from prior cross‐sectional studies that also supported the protective role of higher efflux measures [<xref rid="oby23564-bib-0010" ref-type="bibr">10</xref>]. These data indicated a 25% difference in risk for CVD events per standard deviation of CEC, which translates in our data set to a predicted 12.5% reduction in CVD risk in primates adhering to eTRF for 6 months. The benefit may be greater in older subjects who demonstrated poor plasma CEC at baseline but had larger improvements with eTRF and were comparable to younger adults by the end of the intervention. Reductions in CEC with aging might be secondary to the low‐grade inflammation commonly observed in older people and primates [<xref rid="oby23564-bib-0030" ref-type="bibr">30</xref>, <xref rid="oby23564-bib-0031" ref-type="bibr">31</xref>], with inflammation decreasing the preβ‐1 subpopulation of the HDL particle type, which has the greatest capacity for cholesterol acceptance [<xref rid="oby23564-bib-0032" ref-type="bibr">32</xref>]. This mechanism may also be relevant to the low‐grade inflammation present with unhealthy obesity [<xref rid="oby23564-bib-0033" ref-type="bibr">33</xref>]. Concordant with this is the sustained improvement in HDL CEC observed in patients with obesity subjected to bariatric surgical procedures, but not in the lifestyle‐counseled control group that also had significantly less change in their inflammatory biomarkers [<xref rid="oby23564-bib-0034" ref-type="bibr">34</xref>].</p>
              <p>HDL‐C values do not provide information about the ApoA‐1 containing particle subclasses in circulation. Our study points to a clear shift toward larger HDL particle size, which can result from more TG content, and TG is known to interfere with CEC function [<xref rid="oby23564-bib-0035" ref-type="bibr">35</xref>]. Because total TG in circulation decreased and CEC improved, the larger size is less likely to reflect TG contained within HDL particles. Larger particles can be highly functional depending on their protein, lipid, phospholipid, and micro‐RNA cargo composition. In women transitioning across menopause, CVD disease rates increase substantially, concomitant with loss of larger HDL particles [<xref rid="oby23564-bib-0036" ref-type="bibr">36</xref>]. In these menopausal women, HDL CEC reductions associate with loss of ApoA‐1 levels, highlighting this protein as a key HDL particle feature that confers CVD protection [<xref rid="oby23564-bib-0036" ref-type="bibr">36</xref>]. Herein, we show that eTRF boosted ApoA‐1 concentrations substantially, with a moderate blunting in that increase with aging. Of the protein components measured, ApoA‐1 alone was altered with eTRF. ApoA‐1 composes more than two thirds of the HDL particle protein mass and is the primary protein acquiring cholesterol from membranes in reverse cholesterol transport. Increasing ApoA‐1 is an important outcome because this protein has multiple antioxidant functions in addition to facilitation of cholesterol transport [<xref rid="oby23564-bib-0013" ref-type="bibr">13</xref>].</p>
              <p>The timing of intervention is a relevant feature of the eTRF paradigm. Shifting the feeding window to the early morning hours parallels the highest endogenous cortisol levels and increases in a suite of circadian clock genes [<xref rid="oby23564-bib-0006" ref-type="bibr">6</xref>]. Consistent with eTRF supporting the expression of endogenous diurnal rhythms is that mice with genetic mutations that impair circadian clock gene expression have significant metabolic health improvements with TRF, including circulating cholesterol and TG levels. This suggests that a TRF pattern can induce rhythmic gene expression related to feeding and fasting that is consistent with the mammalian circadian clock [<xref rid="oby23564-bib-0037" ref-type="bibr">37</xref>]. In TRF clinical trials, small nonsignificant changes in HDL‐C have been observed, but in one trial, small improvements were observed in the morning but they were no longer present when measures were repeated in the evening [<xref rid="oby23564-bib-0006" ref-type="bibr">6</xref>, <xref rid="oby23564-bib-0008" ref-type="bibr">8</xref>, <xref rid="oby23564-bib-0024" ref-type="bibr">24</xref>]. In a larger clinical trial comparing feeding windows of early and midday, eTRF was superior in CR, improving body composition and (relevant to our results) the liver marker aspartate transaminase [<xref rid="oby23564-bib-0008" ref-type="bibr">8</xref>]. The repeated fasting and refeeding that occurs in eTRF protocols induces specific gene expression changes in the liver that regulate lipogenesis and cholesterol synthesis. Furthermore, the liver is the major site for ApoA‐1 protein production. Key transcriptional factors modifying lipid and cholesterol metabolism include carbohydrate‐responsive element‐binding protein, liver X receptors (LXR), and sterol regulatory element‐binding protein 1, which are downregulated in the fasted state because of low exposure to glucose and insulin in the portal circulation [<xref rid="oby23564-bib-0038" ref-type="bibr">38</xref>]. Fasting and CR also reduce cytosolic stress in hepatocytes and peripheral blood mononuclear cells, with the protection of chaperone proteins required for proteostasis, protein translation, and autophagy [<xref rid="oby23564-bib-0025" ref-type="bibr">25</xref>, <xref rid="oby23564-bib-0039" ref-type="bibr">39</xref>]. Improved hepatic production of proteins, such as the apolipoproteins, is supported by proteomic analyses of fasting human plasma, in which ApoA‐2, ApoA‐4, and ApoC‐3 were identified as upregulated proteins [<xref rid="oby23564-bib-0040" ref-type="bibr">40</xref>]. Hepatic ApoA‐4 gene transcription is also a key target in fasting–refeeding studies of rodent liver [<xref rid="oby23564-bib-0020" ref-type="bibr">20</xref>]. In alternative day fasting, which is different than eTRF, the peripheral blood mononuclear cell proteome identified lipoprotein metabolism and lipid transporter activity as upregulated pathways, despite no significant change in plasma HDL‐C [<xref rid="oby23564-bib-0025" ref-type="bibr">25</xref>]. We did not observe changes in ApoA‐4, but a more comprehensive proteomics analysis may have detected these and other changes.</p>
              <p>Our study has some limitations. Additional information about the eTRF‐mediated shift in HDL particle composition by proteomic and lipidomic profiling is not available. Furthermore, we relied on a single measure of particle size. Although our study is long for a NHP preclinical trial, it is not long enough to observe definitive CVD outcomes such as atheroma formation. Food intake and activity levels of the individual NHPs were not measured because of the social housing and group feeding environment. As body composition parameters remained consistent throughout study, diet consumption patterns likely shifted to accommodate feeding schedule, which is a phenomenon observed in other time‐restricted fed animals [<xref rid="oby23564-bib-0041" ref-type="bibr">41</xref>]. Finally, we measured plasma CEC rather than HDL CEC as in other studies. Regardless, we observed that the majority of CEC was localized to HDL particles, suggesting that plasma CEC in our study primarily reflects cellular cholesterol efflux to HDL.</p>
              <p>In conclusion, plasma CEC improved significantly with eTRF, regardless of age, in our translationally relevant NHP model. This improvement was seen in concert with increased ApoA‐1, larger HDL particle size, and reduced plasma TG levels. Notably, these beneficial changes in CVD risk biomarkers occurred without changes in body composition. Our study has unique strengths in that it employed a relevant Western diet, containing high fat, simple sugars, and cholesterol in both the eTRF and ad libitum–fed monkeys, and it was of sufficient duration to assess stable and persistent metabolic changes. Our data point to functional HDL improvements with larger HDL particles that contain greater ApoA‐1, and this is the first study of eTRF, to our knowledge, to demonstrate such changes in a preclinical trial of this size and duration. These data add to the growing body of evidence that eTRF is a good strategy, with or without CR, to improve health.</p>
            </sec>
            <sec id="oby23564-sec-0023">
              <title>FUNDING INFORMATION</title>
              <p>This study was funded by NIH P40OD010965, UL1TR001420, and R01HL119962 (to JSP).</p>
            </sec>
            <sec sec-type="COI-statement" id="oby23564-sec-0024">
              <title>CONFLICT OF INTEREST</title>
              <p>The authors declared no conflict of interest.</p>
            </sec>
            <sec sec-type="supplementary-material">
              <title>Supporting information</title>
              <supplementary-material id="oby23564-supitem-0001" position="float" content-type="local-data">
                <caption>
                  <p><bold>Appendix S1</bold> Supporting Information.</p>
                </caption>
                <media xlink:href="OBY-31-75-s001.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <ref-list id="oby23564-bibl-0001" content-type="cited-references">
              <title>REFERENCES</title>
              <ref id="oby23564-bib-0001">
                <label>1</label>
                <mixed-citation publication-type="journal" id="oby23564-cit-0001"><string-name><surname>Heron</surname><given-names>M</given-names></string-name>. <article-title>Deaths: leading causes for 2017</article-title>. <source>Natl Vital Stat Rep</source>. <year>2019</year>;<volume>68</volume>(<issue>6</issue>):<fpage>1</fpage>‐<lpage>77</lpage>.</mixed-citation>
              </ref>
              <ref id="oby23564-bib-0002">
                <label>2</label>
                <mixed-citation publication-type="journal" id="oby23564-cit-0002"><string-name><surname>Schwartz</surname><given-names>JB</given-names></string-name>, <string-name><surname>Schmader</surname><given-names>KE</given-names></string-name>, <string-name><surname>Hanlon</surname><given-names>JT</given-names></string-name>, et al. <article-title>Pharmacotherapy in older adults with cardiovascular disease: report from an American College of Cardiology, American Geriatrics Society, and National Institute on Aging workshop</article-title>. <source>J Am Geriatr Soc</source>. <year>2019</year>;<volume>67</volume>:<fpage>371</fpage>‐<lpage>380</lpage>.<pub-id pub-id-type="pmid">30536694</pub-id></mixed-citation>
              </ref>
              <ref id="oby23564-bib-0003">
                <label>3</label>
                <mixed-citation publication-type="journal" id="oby23564-cit-0003"><string-name><surname>Bolen</surname><given-names>J</given-names></string-name>, <string-name><surname>Hootman</surname><given-names>J</given-names></string-name>, <string-name><surname>Helmick</surname><given-names>CG</given-names></string-name>, et al. <article-title>Arthritis as a potential barrier to physical activity among adults with diabetes ‐ United States, 2005 and 2007</article-title>. <source>MMRW Morb Mortal Wkly Rep</source>. <year>2008</year>;<volume>57 Y</volume>:<fpage>486</fpage>‐<lpage>489</lpage>.</mixed-citation>
              </ref>
              <ref id="oby23564-bib-0004">
                <label>4</label>
                <mixed-citation publication-type="journal" id="oby23564-cit-0004"><string-name><surname>Rothschild</surname><given-names>J</given-names></string-name>, <string-name><surname>Hoddy</surname><given-names>KK</given-names></string-name>, <string-name><surname>Jambazian</surname><given-names>P</given-names></string-name>, <string-name><surname>Varady</surname><given-names>KA</given-names></string-name>. <article-title>Time‐restricted feeding and risk of metabolic disease: a review of human and animal studies</article-title>. <source>Nutr Rev</source>. <year>2014</year>;<volume>72</volume>:<fpage>308</fpage>‐<lpage>318</lpage>.<pub-id pub-id-type="pmid">24739093</pub-id></mixed-citation>
              </ref>
              <ref id="oby23564-bib-0005">
                <label>5</label>
                <mixed-citation publication-type="journal" id="oby23564-cit-0005"><string-name><surname>Gabel</surname><given-names>K</given-names></string-name>, <string-name><surname>Hoddy</surname><given-names>KK</given-names></string-name>, <string-name><surname>Haggerty</surname><given-names>N</given-names></string-name>, et al. <article-title>Effects of 8‐hour time restricted feeding on body weight and metabolic disease risk factors in obese adults: a pilot study</article-title>. <source>Nutr Healthy Aging</source>. <year>2018</year>;<volume>4</volume>:<fpage>345</fpage>‐<lpage>353</lpage>.<pub-id pub-id-type="pmid">29951594</pub-id></mixed-citation>
              </ref>
              <ref id="oby23564-bib-0006">
                <label>6</label>
                <mixed-citation publication-type="journal" id="oby23564-cit-0006"><string-name><surname>Jamshed</surname><given-names>H</given-names></string-name>, <string-name><surname>Beyl</surname><given-names>RA</given-names></string-name>, <string-name><surname>Della Manna</surname><given-names>DL</given-names></string-name>, <string-name><surname>Yang</surname><given-names>ES</given-names></string-name>, <string-name><surname>Ravussin</surname><given-names>E</given-names></string-name>, <string-name><surname>Peterson</surname><given-names>CM</given-names></string-name>. <article-title>Early time‐restricted feeding improves 24‐hour glucose levels and affects markers of the circadian clock, aging, and autophagy in humans</article-title>. <source>Nutrients</source>. <year>2019</year>;<volume>11</volume>:<fpage>1234</fpage>. doi:<pub-id pub-id-type="doi">10.3390/nu11061234</pub-id><pub-id pub-id-type="pmid">31151228</pub-id></mixed-citation>
              </ref>
              <ref id="oby23564-bib-0007">
                <label>7</label>
                <mixed-citation publication-type="journal" id="oby23564-cit-0007"><string-name><surname>Sutton</surname><given-names>EF</given-names></string-name>, <string-name><surname>Beyl</surname><given-names>R</given-names></string-name>, <string-name><surname>Early</surname><given-names>KS</given-names></string-name>, <string-name><surname>Cefalu</surname><given-names>WT</given-names></string-name>, <string-name><surname>Ravussin</surname><given-names>E</given-names></string-name>, <string-name><surname>Peterson</surname><given-names>CM</given-names></string-name>. <article-title>Early time‐restricted feeding improves insulin sensitivity, blood pressure, and oxidative stress even without weight loss in men with prediabetes</article-title>. <source>Cell Metab</source>. <year>2018</year>;<volume>27</volume>:<fpage>1212</fpage>‐<lpage>1221.e3</lpage>.<pub-id pub-id-type="pmid">29754952</pub-id></mixed-citation>
              </ref>
              <ref id="oby23564-bib-0008">
                <label>8</label>
                <mixed-citation publication-type="journal" id="oby23564-cit-0008"><string-name><surname>Xie</surname><given-names>Z</given-names></string-name>, <string-name><surname>Sun</surname><given-names>Y</given-names></string-name>, <string-name><surname>Ye</surname><given-names>Y</given-names></string-name>, et al. <article-title>Randomized controlled trial for time‐restricted eating in healthy volunteers without obesity</article-title>. <source>Nat Commun</source>. <year>2022</year>;<volume>13</volume>:<fpage>1003</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41467-022-28662-5</pub-id><pub-id pub-id-type="pmid">35194047</pub-id></mixed-citation>
              </ref>
              <ref id="oby23564-bib-0009">
                <label>9</label>
                <mixed-citation publication-type="journal" id="oby23564-cit-0009"><string-name><surname>Mure</surname><given-names>LS</given-names></string-name>, <string-name><surname>Le</surname><given-names>HD</given-names></string-name>, <string-name><surname>Benegiamo</surname><given-names>G</given-names></string-name>, et al. <article-title>Diurnal transcriptome atlas of a primate across major neural and peripheral tissues</article-title>. <source>Science</source>. <year>2018</year>;<volume>359</volume>:<elocation-id>eaao0318</elocation-id>. doi:<pub-id pub-id-type="doi">10.1126/science.aao0318</pub-id><pub-id pub-id-type="pmid">29439024</pub-id></mixed-citation>
              </ref>
              <ref id="oby23564-bib-0010">
                <label>10</label>
                <mixed-citation publication-type="journal" id="oby23564-cit-0010"><string-name><surname>Khera</surname><given-names>AV</given-names></string-name>, <string-name><surname>Cuchel</surname><given-names>M</given-names></string-name>, <string-name><surname>de la Llera‐Moya</surname><given-names>M</given-names></string-name>, et al. <article-title>Cholesterol efflux capacity, high‐density lipoprotein function, and atherosclerosis</article-title>. <source>N Engl J Med</source>. <year>2011</year>;<volume>364</volume>:<fpage>127</fpage>‐<lpage>135</lpage>.<pub-id pub-id-type="pmid">21226578</pub-id></mixed-citation>
              </ref>
              <ref id="oby23564-bib-0011">
                <label>11</label>
                <mixed-citation publication-type="journal" id="oby23564-cit-0011"><string-name><surname>Rohatgi</surname><given-names>A</given-names></string-name>, <string-name><surname>Khera</surname><given-names>A</given-names></string-name>, <string-name><surname>Berry</surname><given-names>JD</given-names></string-name>, et al. <article-title>HDL cholesterol efflux capacity and incident cardiovascular events</article-title>. <source>N Engl J Med</source>. <year>2014</year>;<volume>371</volume>:<fpage>2383</fpage>‐<lpage>2393</lpage>.<pub-id pub-id-type="pmid">25404125</pub-id></mixed-citation>
              </ref>
              <ref id="oby23564-bib-0012">
                <label>12</label>
                <mixed-citation publication-type="journal" id="oby23564-cit-0012"><string-name><surname>Kingwell</surname><given-names>BA</given-names></string-name>, <string-name><surname>Chapman</surname><given-names>MJ</given-names></string-name>, <string-name><surname>Kontush</surname><given-names>A</given-names></string-name>, <string-name><surname>Miller</surname><given-names>NE</given-names></string-name>. <article-title>HDL‐targeted therapies: progress, failures and future</article-title>. <source>Nat Rev Drug Discov</source>. <year>2014</year>;<volume>13</volume>:<fpage>445</fpage>‐<lpage>464</lpage>.<pub-id pub-id-type="pmid">24854407</pub-id></mixed-citation>
              </ref>
              <ref id="oby23564-bib-0013">
                <label>13</label>
                <mixed-citation publication-type="journal" id="oby23564-cit-0013"><string-name><surname>Kajani</surname><given-names>S</given-names></string-name>, <string-name><surname>Curley</surname><given-names>S</given-names></string-name>, <string-name><surname>McGillicuddy</surname><given-names>FC</given-names></string-name>. <article-title>Unravelling HDL‐looking beyond the cholesterol surface to the quality within</article-title>. <source>Int J Mol Sci</source>. <year>2018</year>;<volume>19</volume>:<fpage>1971</fpage>. doi:<pub-id pub-id-type="doi">10.3390/ijms19071971</pub-id><pub-id pub-id-type="pmid">29986413</pub-id></mixed-citation>
              </ref>
              <ref id="oby23564-bib-0014">
                <label>14</label>
                <mixed-citation publication-type="journal" id="oby23564-cit-0014"><string-name><surname>Sundfor</surname><given-names>TM</given-names></string-name>, <string-name><surname>Svendsen</surname><given-names>M</given-names></string-name>, <string-name><surname>Tonstad</surname><given-names>S</given-names></string-name>. <article-title>Effect of intermittent versus continuous energy restriction on weight loss, maintenance and cardiometabolic risk: a randomized 1‐year trial</article-title>. <source>Nutr Metab Cardiovasc Dis</source>. <year>2018</year>;<volume>28</volume>:<fpage>698</fpage>‐<lpage>706</lpage>.<pub-id pub-id-type="pmid">29778565</pub-id></mixed-citation>
              </ref>
              <ref id="oby23564-bib-0015">
                <label>15</label>
                <mixed-citation publication-type="journal" id="oby23564-cit-0015"><string-name><surname>Rudel</surname><given-names>LL</given-names></string-name>, <string-name><surname>Bond</surname><given-names>MG</given-names></string-name>, <string-name><surname>Bullock</surname><given-names>BC</given-names></string-name>. <article-title>LDL heterogeneity and atherosclerosis in nonhuman primates</article-title>. <source>Ann N Y Acad Sci</source>. <year>1985</year>;<volume>454</volume>:<fpage>248</fpage>‐<lpage>253</lpage>.<pub-id pub-id-type="pmid">3865611</pub-id></mixed-citation>
              </ref>
              <ref id="oby23564-bib-0016">
                <label>16</label>
                <mixed-citation publication-type="journal" id="oby23564-cit-0016"><string-name><surname>Kavanagh</surname><given-names>K</given-names></string-name>, <string-name><surname>Fairbanks</surname><given-names>LA</given-names></string-name>, <string-name><surname>Bailey</surname><given-names>JN</given-names></string-name>, et al. <article-title>Characterization and heritability of obesity and associated risk factors in vervet monkeys</article-title>. <source>Obesity (Silver Spring)</source>. <year>2007</year>;<volume>15</volume>:<fpage>1666</fpage>‐<lpage>1674</lpage>.<pub-id pub-id-type="pmid">17636084</pub-id></mixed-citation>
              </ref>
              <ref id="oby23564-bib-0017">
                <label>17</label>
                <mixed-citation publication-type="journal" id="oby23564-cit-0017"><string-name><surname>Kavanagh</surname><given-names>K</given-names></string-name>, <string-name><surname>Davis</surname><given-names>AT</given-names></string-name>, <string-name><surname>Peters</surname><given-names>DE</given-names></string-name>, <string-name><surname>LeGrand</surname><given-names>AC</given-names></string-name>, <string-name><surname>Bharadwaj</surname><given-names>MS</given-names></string-name>, <string-name><surname>Molina</surname><given-names>AJ</given-names></string-name>. <article-title>Regulators of mitochondrial quality control differ in subcutaneous fat of metabolically healthy and unhealthy obese monkeys</article-title>. <source>Obesity (Silver Spring)</source>. <year>2017</year>;<volume>25</volume>:<fpage>689</fpage>‐<lpage>696</lpage>.<pub-id pub-id-type="pmid">28236433</pub-id></mixed-citation>
              </ref>
              <ref id="oby23564-bib-0018">
                <label>18</label>
                <mixed-citation publication-type="journal" id="oby23564-cit-0018"><string-name><surname>Jones</surname><given-names>R</given-names></string-name>, <string-name><surname>Pabla</surname><given-names>P</given-names></string-name>, <string-name><surname>Mallinson</surname><given-names>J</given-names></string-name>, et al. <article-title>Two weeks of early time‐restricted feeding (eTRF) improves skeletal muscle insulin and anabolic sensitivity in healthy men</article-title>. <source>Am J Clin Nutr</source>. <year>2020</year>;<volume>112</volume>:<fpage>1015</fpage>‐<lpage>1028</lpage>.<pub-id pub-id-type="pmid">32729615</pub-id></mixed-citation>
              </ref>
              <ref id="oby23564-bib-0019">
                <label>19</label>
                <mixed-citation publication-type="journal" id="oby23564-cit-0019"><string-name><surname>Pureza</surname><given-names>I</given-names></string-name>, <string-name><surname>Macena</surname><given-names>ML</given-names></string-name>, <string-name><surname>da Silva Junior</surname><given-names>AE</given-names></string-name>, <string-name><surname>Praxedes</surname><given-names>DRS</given-names></string-name>, <string-name><surname>Vasconcelos</surname><given-names>LGL</given-names></string-name>, <string-name><surname>Bueno</surname><given-names>NB</given-names></string-name>. <article-title>Effect of early time‐restricted feeding on the metabolic profile of adults with excess weight: a systematic review with meta‐analysis</article-title>. <source>Clin Nutr</source>. <year>2021</year>;<volume>40</volume>:<fpage>1788</fpage>‐<lpage>1799</lpage>.<pub-id pub-id-type="pmid">33139084</pub-id></mixed-citation>
              </ref>
              <ref id="oby23564-bib-0020">
                <label>20</label>
                <mixed-citation publication-type="journal" id="oby23564-cit-0020"><string-name><surname>Kinouchi</surname><given-names>K</given-names></string-name>, <string-name><surname>Magnan</surname><given-names>C</given-names></string-name>, <string-name><surname>Ceglia</surname><given-names>N</given-names></string-name>, et al. <article-title>Fasting imparts a switch to alternative daily pathways in liver and muscle</article-title>. <source>Cell Rep</source>. <year>2018</year>;<volume>25</volume>:<fpage>3299</fpage>‐<lpage>3314.e6</lpage>.<pub-id pub-id-type="pmid">30566858</pub-id></mixed-citation>
              </ref>
              <ref id="oby23564-bib-0021">
                <label>21</label>
                <mixed-citation publication-type="journal" id="oby23564-cit-0021"><string-name><surname>Saleheen</surname><given-names>D</given-names></string-name>, <string-name><surname>Scott</surname><given-names>R</given-names></string-name>, <string-name><surname>Javad</surname><given-names>S</given-names></string-name>, et al. <article-title>Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case‐control study</article-title>. <source>Lancet Diabetes Endocrinol</source>. <year>2015</year>;<volume>3</volume>:<fpage>507</fpage>‐<lpage>513</lpage>.<pub-id pub-id-type="pmid">26025389</pub-id></mixed-citation>
              </ref>
              <ref id="oby23564-bib-0022">
                <label>22</label>
                <mixed-citation publication-type="journal" id="oby23564-cit-0022"><string-name><surname>Allain</surname><given-names>CC</given-names></string-name>, <string-name><surname>Poon</surname><given-names>LS</given-names></string-name>, <string-name><surname>Chan</surname><given-names>CS</given-names></string-name>, <string-name><surname>Richmond</surname><given-names>W</given-names></string-name>, <string-name><surname>Fu</surname><given-names>PC</given-names></string-name>. <article-title>Enzymatic determination of total serum cholesterol</article-title>. <source>Clin Chem</source>. <year>1974</year>;<volume>20</volume>:<fpage>470</fpage>‐<lpage>475</lpage>.<pub-id pub-id-type="pmid">4818200</pub-id></mixed-citation>
              </ref>
              <ref id="oby23564-bib-0023">
                <label>23</label>
                <mixed-citation publication-type="journal" id="oby23564-cit-0023"><string-name><surname>Kavanagh</surname><given-names>K</given-names></string-name>, <string-name><surname>Davis</surname><given-names>MA</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>L</given-names></string-name>, et al. <article-title>Estrogen decreases atherosclerosis in part by reducing hepatic acyl‐CoA:cholesterol acyltransferase 2 (ACAT2) in monkeys</article-title>. <source>Arterioscler Thromb Vasc Biol</source>. <year>2009</year>;<volume>29</volume>:<fpage>1471</fpage>‐<lpage>1477</lpage>.<pub-id pub-id-type="pmid">19759374</pub-id></mixed-citation>
              </ref>
              <ref id="oby23564-bib-0024">
                <label>24</label>
                <mixed-citation publication-type="journal" id="oby23564-cit-0024"><string-name><surname>Thomas</surname><given-names>EA</given-names></string-name>, <string-name><surname>Zaman</surname><given-names>A</given-names></string-name>, <string-name><surname>Sloggett</surname><given-names>KJ</given-names></string-name>, et al. <article-title>Early time‐restricted eating compared with daily caloric restriction: a randomized trial in adults with obesity</article-title>. <source>Obesity (Silver Spring)</source>. <year>2022</year>;<volume>30</volume>:<fpage>1027</fpage>‐<lpage>1038</lpage>.<pub-id pub-id-type="pmid">35470974</pub-id></mixed-citation>
              </ref>
              <ref id="oby23564-bib-0025">
                <label>25</label>
                <mixed-citation publication-type="journal" id="oby23564-cit-0025"><string-name><surname>Stekovic</surname><given-names>S</given-names></string-name>, <string-name><surname>Hofer</surname><given-names>SJ</given-names></string-name>, <string-name><surname>Tripolt</surname><given-names>N</given-names></string-name>, et al. <article-title>Alternate day fasting improves physiological and molecular markers of aging in healthy, non‐obese humans</article-title>. <source>Cell Metab</source>. <year>2019</year>;<volume>30</volume>:<fpage>462</fpage>‐<lpage>476.e6</lpage>.<pub-id pub-id-type="pmid">31471173</pub-id></mixed-citation>
              </ref>
              <ref id="oby23564-bib-0026">
                <label>26</label>
                <mixed-citation publication-type="journal" id="oby23564-cit-0026"><string-name><surname>Schroder</surname><given-names>JD</given-names></string-name>, <string-name><surname>Falqueto</surname><given-names>H</given-names></string-name>, <string-name><surname>Manica</surname><given-names>A</given-names></string-name>, et al. <article-title>Effects of time‐restricted feeding in weight loss, metabolic syndrome and cardiovascular risk in obese women</article-title>. <source>J Transl Med</source>. <year>2021</year>;<volume>19</volume>:<fpage>3</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s12967-020-02687-0</pub-id><pub-id pub-id-type="pmid">33407612</pub-id></mixed-citation>
              </ref>
              <ref id="oby23564-bib-0027">
                <label>27</label>
                <mixed-citation publication-type="journal" id="oby23564-cit-0027"><string-name><surname>de Cabo</surname><given-names>R</given-names></string-name>, <string-name><surname>Mattson</surname><given-names>MP</given-names></string-name>. <article-title>Effects of intermittent fasting on health, aging, and disease</article-title>. <source>N Engl J Med</source>. <year>2019</year>;<volume>381</volume>:<fpage>2541</fpage>‐<lpage>2551</lpage>.<pub-id pub-id-type="pmid">31881139</pub-id></mixed-citation>
              </ref>
              <ref id="oby23564-bib-0028">
                <label>28</label>
                <mixed-citation publication-type="miscellaneous" id="oby23564-cit-0028"><collab collab-type="authors">World Health Organization</collab>
. <article-title>Obesity and overweight. Updated June 9, 2021. Accessed June 23, 2019</article-title>. <ext-link xlink:href="https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight" ext-link-type="uri">https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight</ext-link>
</mixed-citation>
              </ref>
              <ref id="oby23564-bib-0029">
                <label>29</label>
                <mixed-citation publication-type="journal" id="oby23564-cit-0029"><string-name><surname>Xiang</surname><given-names>AS</given-names></string-name>, <string-name><surname>Kingwell</surname><given-names>BA</given-names></string-name>. <article-title>Rethinking good cholesterol: a clinicians' guide to understanding HDL</article-title>. <source>Lancet Diabetes Endocrinol</source>. <year>2019</year>;<volume>7</volume>:<fpage>575</fpage>‐<lpage>582</lpage>.<pub-id pub-id-type="pmid">30910502</pub-id></mixed-citation>
              </ref>
              <ref id="oby23564-bib-0030">
                <label>30</label>
                <mixed-citation publication-type="journal" id="oby23564-cit-0030"><string-name><surname>Wu</surname><given-names>IC</given-names></string-name>, <string-name><surname>Lin</surname><given-names>CC</given-names></string-name>, <string-name><surname>Hsiung</surname><given-names>CA</given-names></string-name>. <article-title>Emerging roles of frailty and inflammaging in risk assessment of age‐related chronic diseases in older adults: the intersection between aging biology and personalized medicine</article-title>. <source>Biomedicine (Taipei)</source>. <year>2015</year>;<volume>5</volume>:<fpage>1</fpage>. doi:<pub-id pub-id-type="doi">10.7603/s40681-015-0001-1</pub-id><pub-id pub-id-type="pmid">25722960</pub-id></mixed-citation>
              </ref>
              <ref id="oby23564-bib-0031">
                <label>31</label>
                <mixed-citation publication-type="journal" id="oby23564-cit-0031"><string-name><surname>Wilson</surname><given-names>QN</given-names></string-name>, <string-name><surname>Wells</surname><given-names>M</given-names></string-name>, <string-name><surname>Davis</surname><given-names>AT</given-names></string-name>, et al. <article-title>Greater microbial translocation and vulnerability to metabolic disease in healthy aged female monkeys</article-title>. <source>Sci Rep</source>. <year>2018</year>;<volume>8</volume>:<fpage>11373</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41598-018-29473-9</pub-id><pub-id pub-id-type="pmid">30054517</pub-id></mixed-citation>
              </ref>
              <ref id="oby23564-bib-0032">
                <label>32</label>
                <mixed-citation publication-type="journal" id="oby23564-cit-0032"><string-name><surname>de la Llera</surname><given-names>MM</given-names></string-name>, <string-name><surname>McGillicuddy</surname><given-names>FC</given-names></string-name>, <string-name><surname>Hinkle</surname><given-names>CC</given-names></string-name>, et al. <article-title>Inflammation modulates human HDL composition and function in vivo</article-title>. <source>Atherosclerosis</source>. <year>2012</year>;<volume>222</volume>:<fpage>390</fpage>‐<lpage>394</lpage>.<pub-id pub-id-type="pmid">22456230</pub-id></mixed-citation>
              </ref>
              <ref id="oby23564-bib-0033">
                <label>33</label>
                <mixed-citation publication-type="journal" id="oby23564-cit-0033"><string-name><surname>Bell</surname><given-names>JA</given-names></string-name>, <string-name><surname>Hamer</surname><given-names>M</given-names></string-name>, <string-name><surname>Batty</surname><given-names>GD</given-names></string-name>, <string-name><surname>Singh‐Manoux</surname><given-names>A</given-names></string-name>, <string-name><surname>Sabia</surname><given-names>S</given-names></string-name>, <string-name><surname>Kivimäki</surname><given-names>M</given-names></string-name>. <article-title>Incidence of metabolic risk factors among healthy obese adults: 20‐year follow‐up</article-title>. <source>J Am Coll Cardiol</source>. <year>2015</year>;<volume>66</volume>:<fpage>871</fpage>‐<lpage>873</lpage>.<pub-id pub-id-type="pmid">26271072</pub-id></mixed-citation>
              </ref>
              <ref id="oby23564-bib-0034">
                <label>34</label>
                <mixed-citation publication-type="journal" id="oby23564-cit-0034"><string-name><surname>Lorkowski</surname><given-names>SW</given-names></string-name>, <string-name><surname>Brubaker</surname><given-names>G</given-names></string-name>, <string-name><surname>Rotroff</surname><given-names>DM</given-names></string-name>, et al. <article-title>Bariatric surgery improves HDL function examined by ApoA1 exchange rate and cholesterol efflux capacity in patients with obesity and type 2 diabetes</article-title>. <source>Biomolecules</source>. <year>2020</year>;<volume>10</volume>:<fpage>551</fpage>. doi:<pub-id pub-id-type="doi">10.3390/biom10040551</pub-id><pub-id pub-id-type="pmid">32260470</pub-id></mixed-citation>
              </ref>
              <ref id="oby23564-bib-0035">
                <label>35</label>
                <mixed-citation publication-type="journal" id="oby23564-cit-0035"><string-name><surname>Greene</surname><given-names>DJ</given-names></string-name>, <string-name><surname>Skeggs</surname><given-names>JW</given-names></string-name>, <string-name><surname>Morton</surname><given-names>RE</given-names></string-name>. <article-title>Elevated triglyceride content diminishes the capacity of high density lipoprotein to deliver cholesteryl esters via the scavenger receptor class B type I (SR‐BI)</article-title>. <source>J Biol Chem</source>. <year>2001</year>;<volume>276</volume>:<fpage>4804</fpage>‐<lpage>4811</lpage>.<pub-id pub-id-type="pmid">11067853</pub-id></mixed-citation>
              </ref>
              <ref id="oby23564-bib-0036">
                <label>36</label>
                <mixed-citation publication-type="journal" id="oby23564-cit-0036"><string-name><surname>El Khoudary</surname><given-names>SR</given-names></string-name>, <string-name><surname>Chen</surname><given-names>X</given-names></string-name>, <string-name><surname>Nasr</surname><given-names>AN</given-names></string-name>, et al. <article-title>HDL (high‐density lipoprotein) subclasses, lipid content, and function trajectories across the menopause transition: SWAN‐HDL study</article-title>. <source>Arterioscler Thromb Vasc Biol</source>. <year>2021</year>;<volume>41</volume>:<fpage>951</fpage>‐<lpage>961</lpage>.<pub-id pub-id-type="pmid">33267661</pub-id></mixed-citation>
              </ref>
              <ref id="oby23564-bib-0037">
                <label>37</label>
                <mixed-citation publication-type="journal" id="oby23564-cit-0037"><string-name><surname>Chaix</surname><given-names>A</given-names></string-name>, <string-name><surname>Lin</surname><given-names>T</given-names></string-name>, <string-name><surname>Le</surname><given-names>HD</given-names></string-name>, <string-name><surname>Chang</surname><given-names>MW</given-names></string-name>, <string-name><surname>Panda</surname><given-names>S</given-names></string-name>. <article-title>Time‐restricted feeding prevents obesity and metabolic syndrome in mice lacking a circadian clock</article-title>. <source>Cell Metab</source>. <year>2019</year>;<volume>29</volume>:<elocation-id>303‐319.e4</elocation-id>.<pub-id pub-id-type="pmid">30174302</pub-id></mixed-citation>
              </ref>
              <ref id="oby23564-bib-0038">
                <label>38</label>
                <mixed-citation publication-type="journal" id="oby23564-cit-0038"><string-name><surname>Bideyan</surname><given-names>L</given-names></string-name>, <string-name><surname>Nagari</surname><given-names>R</given-names></string-name>, <string-name><surname>Tontonoz</surname><given-names>P</given-names></string-name>. <article-title>Hepatic transcriptional responses to fasting and feeding</article-title>. <source>Genes Dev</source>. <year>2021</year>;<volume>35</volume>:<fpage>635</fpage>‐<lpage>657</lpage>.<pub-id pub-id-type="pmid">33888557</pub-id></mixed-citation>
              </ref>
              <ref id="oby23564-bib-0039">
                <label>39</label>
                <mixed-citation publication-type="journal" id="oby23564-cit-0039"><string-name><surname>Gat‐Yablonski</surname><given-names>G</given-names></string-name>, <string-name><surname>Finka</surname><given-names>A</given-names></string-name>, <string-name><surname>Pinto</surname><given-names>G</given-names></string-name>, <string-name><surname>Quadroni</surname><given-names>M</given-names></string-name>, <string-name><surname>Shtaif</surname><given-names>B</given-names></string-name>, <string-name><surname>Goloubinoff</surname><given-names>P</given-names></string-name>. <article-title>Quantitative proteomics of rat livers shows that unrestricted feeding is stressful for proteostasis with implications on life span</article-title>. <source>Aging</source>. <year>2016</year>;<volume>8</volume>:<fpage>1735</fpage>‐<lpage>1758</lpage>.<pub-id pub-id-type="pmid">27508340</pub-id></mixed-citation>
              </ref>
              <ref id="oby23564-bib-0040">
                <label>40</label>
                <mixed-citation publication-type="journal" id="oby23564-cit-0040"><string-name><surname>Harney</surname><given-names>DJ</given-names></string-name>, <string-name><surname>Hutchison</surname><given-names>AT</given-names></string-name>, <string-name><surname>Hatchwell</surname><given-names>L</given-names></string-name>, et al. <article-title>Proteomic analysis of human plasma during intermittent fasting</article-title>. <source>J Proteome Res</source>. <year>2019</year>;<volume>18</volume>:<fpage>2228</fpage>‐<lpage>2240</lpage>.<pub-id pub-id-type="pmid">30892045</pub-id></mixed-citation>
              </ref>
              <ref id="oby23564-bib-0041">
                <label>41</label>
                <mixed-citation publication-type="journal" id="oby23564-cit-0041"><string-name><surname>Ligout</surname><given-names>S</given-names></string-name>, <string-name><surname>Si</surname><given-names>X</given-names></string-name>, <string-name><surname>Vlaeminck</surname><given-names>H</given-names></string-name>, <string-name><surname>Lyn</surname><given-names>S</given-names></string-name>. <article-title>Cats reorganise their feeding behaviours when moving from ad libitum to restricted feeding</article-title>. <source>J Feline Med Surg</source>. <year>2020</year>;<volume>22</volume>:<fpage>953</fpage>‐<lpage>958</lpage>.<pub-id pub-id-type="pmid">32149574</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
